Filing Details

Accession Number:
0001999371-25-001208
Form Type:
13G Filing
Publication Date:
2025-02-04 19:00:00
Filed By:
David Capital Partners, LLC
Company:
Lifecore Biomedical Inc. (NASDAQ:LFCR)
Filing Date:
2025-02-05
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
David Capital Partners, LLC 0 1,803,000 4.87%
David Capital Partners Fund, LP 0 1,803,000 4.87%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Percentage reported in row (11) based on 37,025,331 shares of Common Stock (as defined below) of the Issuer (as defined below) outstanding as of December 26, 2024, based on the Issuer's Form 10-Q filed with the Securities and Exchange Commission ("Commission") on January 2, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  Percentage reported in row (11) based on 37,025,331 shares of Common Stock (as defined below) of the Issuer (as defined below) outstanding as of December 26, 2024, based on the Issuer's Form 10-Q filed with the Securities and Exchange Commission ("Commission") on January 2, 2025.


SCHEDULE 13G


 
David Capital Partners, LLC
 
Signature:Adam J. Patinkin
Name/Title:Managing Member
Date:02/04/2025
 
David Capital Partners Fund, LP
 
Signature:Adam J. Patinkin
Name/Title:Managing Member of David Capital Partners, LLC, the
Date:02/04/2025